FDA announces end to Wegovy and Ozempic drug shortages

Ozempic and Wegovy are no longer in shortage, FDA says
Blockbuster weight-loss and diabetes drugs Wegovy and Ozempic are no longer in shortage, the US Food and Drug Administration said on Friday.
FDA announces end to Wegovy and Ozempic drug shortages, but it could mean higher prices
The FDA has announced that the shortage of Wegovy and Ozempic, medications used for weight loss and diabetes management, is over.
Generic Wegovy, Ozempic compounds may become harder to get as FDA removes drug from shortage list
Compounding pharmacies producing cheaper semaglutide products have been given notice they will soon have to stop, as the drug is no longer on the FDA shortage list.
Novo’s Weight Loss Drugs Removed from FDA Shortage List
The FDA said weight-loss and diabetes drugs Wegovy and Ozempic are no longer on shortage list. The U.S. Food and Drug Administration said on Friday there was no longer a shortage of Novo Nordisk’s popular weight-loss and diabetes drugs,
FDA says Ozempic, Wegovy are not in short supply anymore, which could impact prices
The U.S. Food and Drug Administration said Ozempic and Wegovy, the popular GLP-1 drugs for diabetes and weight loss, are no longer in short supply. CBS News New York reporter Ali Bauman reports on whether the supply change could lead to consumers paying more.
Shortage of popular drugs Wegovy and Ozempic is over, FDA says.
The FDA said the shortage of Novo Nordisk's weight-loss drugs Wegovy and Ozempic is resolved. The move could limit cheaper compounded versions
How the FDA's approval for food additives works, and why experts say a loophole allows companies to bypass it
Experts say that for decades, a legal loophole has allowed companies to include chemical additives that could be potentially ...
FDA’s food safety head resigns over mass layoffs
Jim Jones, the head of the Food and Drug Administration’s (FDA) food division, resigned Monday, citing the mass firings of ...
STAT2d
Dozens of attorneys general urge FDA to crack down on counterfeit obesity drugs
More than three dozen attorneys general are urging the FDA to take “decisive action” against counterfeit obesity drugs.
FDA To Review Teva and Alvotech Drug That Could Compete With Regeneron's Eylea
Key Takeaways Teva Pharmaceutical Industries and partner Alvotech said the Food and Drug Administration agreed to review ...
NY legislator proposes ban on flavored nicotine pouches including Zyn, despite FDA backing
A state legislator is moving to outlaw the sale of nicotine pouches, despite the federal Food and Drug Administration’s ...
Trump administration cuts FDA workers in food safety, medical device review
The Trump administration’s effort to slash the size of the federal workforce reached the Food and Drug Administration.
ABC News7d
Trump administration cuts reach FDA employees in food safety, medical devices and tobacco products
The Trump administration’s effort ... whether those employees were exempted. FDA inspectors are responsible for overseeing thousands of food, drug, tobacco and medical device facilities ...
Top FDA food safety official's resignation letter warns firings will backfire on RFK Jr.
James Jones resigned as FDA deputy commissioner and said the Trump administration's "indiscriminate" job cuts show "disdain for the very people necessary to implement your agenda." ...